SENSEX 78,581.00
+ 152.05
NIFTY 24,624.65
+ 9.75
CRUDEOIL 7,159.00
Biocon's Q1 revenue rises 10% to ₹4,336 crore, driven by a 355% net profit surge from its biosimilars business.
Biocon's Q1 net profit jumped 355% to ₹141 crore, with biosimilars (+16%) and generics (+21%) driving revenue to ₹4,336 crore. Pharma biosimilar market consolidation signals rising infrastructure demand for supply-chain traceability, regulatory compliance, and health IT platforms.
SENSEX 78,581.00
+ 152.05
NIFTY 24,624.65
+ 9.75
CRUDEOIL 7,159.00

Consolidated net profit in Q1 rises to ₹2,895 crore ($303.54 million) from ₹2,279 crore a year earlier

During January-March, the company's revenue from operations increased to ₹30,813 crore from ₹29,316 crore recorded in the fourth…

Revenue stood at ₹1,523.7 crore, registering a robust 62.7% y-o-y growth, driven by strong execution momentum in the smart…

ICICI Bank's Q1 net profit rises 13.88% to ₹15,440 crore, driven by strong advances and improved asset quality.

Cipla shares soared 3.7% on Friday despite a 39% decline in first-quarter PAT, with the stock trading at ₹1,426.40 on the NSE.

SBI's Q1 net profit rises 10% to ₹21,121 crore, driven by strong net interest income and reduced NPA provisions.